A three-year review of data on the Combo Dual Therapy Stent was presented at the Joint Interventional Meeting (JIM) 2015 in Rome. These data demonstrate the healing benefits of the Combo Dual Therapy Stent in the treatment of coronary artery disease in the short, medium and long-term.

A comparison of iFR and FFR cut offs for whether a stent is needed in a coronary lesion.

As an early adopter of fractional flow reserve (FFR) for the diagnosis of ischemia, my initial decision to transition from angiographic-guided treatment to physiologic-guided treatment was driven by a desire to ensure that we were treating lesions appropriately. Despite countless studies indicating the weakness of the angiogram, far too many operators still rely on it for treatment guidance. The coronary angiogram is limited and does not measure the extent to which a stenosis is restricting blood flow.

Biotronik announced that its ProMRI and ProMRI AFFIRM studies have been published inĀ Heart Rhythm,Ā the official journal of the Heart Rhythm Society, validating the safety testing of Biotronikā€™sĀ ProMRIĀ technology.

The Centers for Medicare and Medicaid Services (CMS) has released theĀ 2015 National Impact Assessment of Quality Measures ReportĀ (2015 Impact Report).

A new, online report predicts where American hospitals will spend billions on healthcare technology in 2015, centering on ICD-10 migration and population health management solutions.

PE, pulmonary embolism, thrombolysis, Ekos, Ekosonic

The continuity within clinical conference topics from year to year and how presentations augment one another tells us a lot about where medicine is headed. Pulmonary embolism (PE) therapies were a key subject presented at the 2013 and 2014 Veith Symposium meetings in New York.Ā 
Ā 
Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now